Selected Papers from the 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics (ECMC-P 2026)
A Special Issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: 30 June 2027 | Viewed by 183
Editors
2. Laboratory of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
Interests: medicinal chemistry; organic synthesis; heterocycles; P-glycoprotein; anticancer; antimicrobials; chiral drugs; marine natural products
Special Issues, Collections and Topics in MDPI journals
Interests: antisense; aptamers; antiviral RNAs; viral RNA genomes; structure/function of RNA domains; RNA virus; orthoflavivirus
Special Issues, Collections and Topics in MDPI journals
Interests: drug development; antiestrogens; in silico; breast cancer; design and synthesis; synthetic methods; amphetamines; anticancer drug design; carbapenem antibiotics; chemistry of drug metabolism; chemistry of drug receptor interactions; design and synthesis of drugs; molecular modelling of estrogen receptor antagonists; pharmacologically active heterocycles
Special Issues, Collections and Topics in MDPI journals
Interests: microencapsulation; nanoemulsions; biopharmacy; formulation; pharmaceutical engineering
Special Issues, Collections and Topics in MDPI journals
Interests: ocular drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As it is the tradition of the ECMC series and IECP series, and it is indicated in the information of the 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics (ECMC-P 2026) https://sciforum.net/event/ECMC-P2026?section=#welcome, we are pleased to announce the launch of a Special Issue in Pharmaceuticals and in Pharmaceutics journals to collect the most interesting contributions of this ECMC-P2026, which will be hosted on the online platform sciforum.net, throughout the month of November 2026. We invite authors to contribute an extended version of the work presented at the Conference in the form of a full research article describing their original experimental results.
Authors are encouraged to use the Microsoft Word template or LaTeX template to prepare their manuscript. Using the template file provided by Pharmaceuticals (ISSN 1424-8247) or Pharmaceutics journals (ISSN 1999-4923). All manuscripts will undergo peer review and, once accepted, will be published in this Special Issue. A 20% discount will be applied to the article processing charge.
Dr. Maria Emília De Sousa
Dr. Alfredo Berzal-Herranz
Prof. Dr. Mary J. Meegan
Prof. Dr. Thierry Vandamme
Prof. Dr. Francisco Javier Otero-Espinar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- new small molecules as drug candidates
- natural products and biopharmaceuticals
- novel methodologies and AI
- new modalities in drug discovery
- radiopharmaceuticals
- nanomedicine and nanotechnology
- formulation, drug delivery, and controlled release
- biopharmaceutics, disposition, pharmacokinetics and pharmacodynamics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
